Factor eight inhibitor bypass activity (FEIBA) in the management of bleeds in hemophilia patients with high-titer inhibitors.
about
Pharmacological characteristics of a novel, recombinant fusion protein linking coagulation factor VIIa with albumin (rVIIa-FP)Reversal of warfarin-induced hemorrhage in the emergency department.International recommendations on the diagnosis and treatment of patients with acquired hemophilia AAchievements, challenges and unmet needs for haemophilia patients with inhibitors: Report from a symposium in Paris, France on 20 November 2014.The use of PEGylated liposomes in the development of drug delivery applications for the treatment of hemophilia.Advances in bypassing agent therapy for hemophilia patients with inhibitors to close care gaps and improve outcomesFactor VIII associated with lipidic nanoparticles retains efficacy in the presence of anti-factor VIII antibodies in hemophilia A mice.
P2860
Q34200694-EA4FFDBA-8E83-4D2B-9A5A-3B40286C0B0DQ35608280-F5425455-FA04-44A3-A8D0-A0A916C68D22Q37146064-1E4195DC-42DD-4E78-A6E9-A0F300EA5F47Q37185097-3652B043-588A-4C73-953E-BB56D64D7CD6Q37790614-402FBB72-1C72-4E2D-8D97-F0F2D90CED1EQ38235951-8165628E-2DBD-485D-9BAA-52EF47857E5DQ39600375-50F65F59-B7A3-4245-94B6-0AB0F3271CFB
P2860
Factor eight inhibitor bypass activity (FEIBA) in the management of bleeds in hemophilia patients with high-titer inhibitors.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Factor eight inhibitor bypass ...... ts with high-titer inhibitors.
@en
type
label
Factor eight inhibitor bypass ...... ts with high-titer inhibitors.
@en
prefLabel
Factor eight inhibitor bypass ...... ts with high-titer inhibitors.
@en
P2860
P921
P1476
Factor eight inhibitor bypass ...... nts with high-titer inhibitors
@en
P2093
Geir E Tjønnfjord
Pål Andre Holme
P2860
P304
P407
P577
2007-01-01T00:00:00Z